Successful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
Dave Li, MD, PhD
Advertisement
Articles by Dave Li, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
2
Applying Systems Thinking to the Future of Clinical R&D
3
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
4
ACT Brief: CRO Partnership in Program Recruitment, Psychedelic Trial Design Guidance, and Breast Cancer Pathway Inhibitor
5